We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Adtalem Arm Partners With Dillard, Boosts Physician Diversity
Read MoreHide Full Article
In order to increase the numbers of African-American doctors in the United States, Adtalem Global Education Inc.‘s (ATGE - Free Report) Ross University School of Medicine (“RUSM”) has partnered with Louisiana-based Dillard University.
Per the agreement, eligible Dillard students will be able to receive a scholarship for the first semester covering full tuition in the medical school. They will also have to spend their initial two years of school at the RUSM campus in Barbados.
Adtalem’s Commitment to Address Diversity in Medicine
RUSM — one of the medical and veterinary schools of Adtalem — has a diverse student population, of which nearly one-fourth of the total students are African-American and Hispanic. Of the total U.S. physicians, African Americans make up only 6%. Notably, RUSM African-American graduates were more than 80 students, surpassing the average of eight in most U.S. medical schools.
On that note, RUSM recently agreed upon a similar partnership with Charles Drew University of Medicine and Science, Agricultural and Mechanical University, as well as Tuskegee University. Also, the company entered into the Historically Black Colleges and Universities (“HBCU”) Partnership Challenge, created by the Congressional Bipartisan HBCU Caucus, to increase diversity in key workforce sectors.
Tie-ups with corporations, hospitals, government agencies and professional organizations enabled the company to reduce exposure to Title IV funding.
Coming to price performance, shares of Adtalem have declined 5.6% so far this year against its industry’s 30.8% growth. The company has been recording lower profits over the last few quarters. The declining earnings were mainly due to certain restructuring charges related to the closing of the Ross University School of Medicine campus in Dominica and real estate consolidations.
Nevertheless, collaborations and strategic initiatives taken up by Adtalem will probably help to spur growth and regain momentum. Notably, in the second quarter of fiscal 2019, growth of new student enrollment was 4.9% and that of total student enrollment was 2.9% year over year. The company remains optimistic about the demand trend in the medical and healthcare segment from both students and employees.
Zacks Rank & Key Picks
Currently, Adtalem carries a Zacks Rank #4 (Sell). Some better-ranked stocks in the same space include Strategic Education, Inc. (STRA - Free Report) , YogaWorks, Inc. and Bright Horizons Family Solutions Inc. (BFAM - Free Report) . While Strategic Education and YogaWorks sport a Zacks Rank #1 (Strong Buy), Bright Horizons carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Strategic Education, YogaWorks and Bright Horizons’ earnings for the current year are expected to grow 36.2%, 17.1%, and 12.8%, respectively.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Adtalem Arm Partners With Dillard, Boosts Physician Diversity
In order to increase the numbers of African-American doctors in the United States, Adtalem Global Education Inc.‘s (ATGE - Free Report) Ross University School of Medicine (“RUSM”) has partnered with Louisiana-based Dillard University.
.jpg)
Per the agreement, eligible Dillard students will be able to receive a scholarship for the first semester covering full tuition in the medical school. They will also have to spend their initial two years of school at the RUSM campus in Barbados.
Adtalem’s Commitment to Address Diversity in Medicine
RUSM — one of the medical and veterinary schools of Adtalem — has a diverse student population, of which nearly one-fourth of the total students are African-American and Hispanic. Of the total U.S. physicians, African Americans make up only 6%. Notably, RUSM African-American graduates were more than 80 students, surpassing the average of eight in most U.S. medical schools.
On that note, RUSM recently agreed upon a similar partnership with Charles Drew University of Medicine and Science, Agricultural and Mechanical University, as well as Tuskegee University. Also, the company entered into the Historically Black Colleges and Universities (“HBCU”) Partnership Challenge, created by the Congressional Bipartisan HBCU Caucus, to increase diversity in key workforce sectors.
Tie-ups with corporations, hospitals, government agencies and professional organizations enabled the company to reduce exposure to Title IV funding.
Coming to price performance, shares of Adtalem have declined 5.6% so far this year against its industry’s 30.8% growth. The company has been recording lower profits over the last few quarters. The declining earnings were mainly due to certain restructuring charges related to the closing of the Ross University School of Medicine campus in Dominica and real estate consolidations.
Nevertheless, collaborations and strategic initiatives taken up by Adtalem will probably help to spur growth and regain momentum. Notably, in the second quarter of fiscal 2019, growth of new student enrollment was 4.9% and that of total student enrollment was 2.9% year over year. The company remains optimistic about the demand trend in the medical and healthcare segment from both students and employees.
Zacks Rank & Key Picks
Currently, Adtalem carries a Zacks Rank #4 (Sell). Some better-ranked stocks in the same space include Strategic Education, Inc. (STRA - Free Report) , YogaWorks, Inc. and Bright Horizons Family Solutions Inc. (BFAM - Free Report) . While Strategic Education and YogaWorks sport a Zacks Rank #1 (Strong Buy), Bright Horizons carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Strategic Education, YogaWorks and Bright Horizons’ earnings for the current year are expected to grow 36.2%, 17.1%, and 12.8%, respectively.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>